Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxj3
|
ENSMUSG00000032998.10 | forkhead box J3 |
Tbl1xr1
|
ENSMUSG00000027630.8 | transducin (beta)-like 1X-linked receptor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_119540226_119540466 | Foxj3 | 176 | 0.834899 | 0.47 | 3.4e-04 | Click! |
chr4_119609673_119609824 | Foxj3 | 11594 | 0.136222 | -0.38 | 4.1e-03 | Click! |
chr4_119539709_119540211 | Foxj3 | 181 | 0.720671 | 0.28 | 3.8e-02 | Click! |
chr4_119589443_119589736 | Foxj3 | 31753 | 0.095205 | -0.21 | 1.2e-01 | Click! |
chr3_22190612_22190763 | Tbl1xr1 | 12505 | 0.228128 | 0.59 | 2.5e-06 | Click! |
chr3_22076598_22077433 | Tbl1xr1 | 79 | 0.934548 | 0.53 | 3.5e-05 | Click! |
chr3_22078324_22078475 | Tbl1xr1 | 1115 | 0.412083 | 0.22 | 1.1e-01 | Click! |
chr3_22168545_22168696 | Tbl1xr1 | 19678 | 0.212677 | 0.10 | 4.7e-01 | Click! |
chr3_22181127_22181278 | Tbl1xr1 | 21990 | 0.207054 | -0.08 | 5.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_112695608_112695943 | 96.63 |
Gm18883 |
predicted gene, 18883 |
3904 |
0.16 |
chr12_3236518_3237725 | 73.32 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr9_124439906_124440949 | 50.20 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chrY_90739614_90740540 | 48.57 |
Mid1-ps1 |
midline 1, pseudogene 1 |
12980 |
0.18 |
chr5_32713265_32714499 | 43.10 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chr14_14350947_14351733 | 39.46 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr11_112501711_112502406 | 33.85 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr17_52601056_52601789 | 33.69 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr9_45663652_45664379 | 32.37 |
Dscaml1 |
DS cell adhesion molecule like 1 |
8822 |
0.19 |
chr13_84059070_84059621 | 31.94 |
Gm17750 |
predicted gene, 17750 |
5427 |
0.24 |
chr11_88582890_88583759 | 29.63 |
Msi2 |
musashi RNA-binding protein 2 |
6823 |
0.27 |
chr8_47284778_47285157 | 29.49 |
Stox2 |
storkhead box 2 |
4395 |
0.28 |
chr13_84783122_84783632 | 29.16 |
Gm26913 |
predicted gene, 26913 |
92436 |
0.09 |
chrX_75673394_75674325 | 29.09 |
Gm15065 |
predicted gene 15065 |
31550 |
0.13 |
chr6_81660570_81661025 | 28.70 |
Gm26264 |
predicted gene, 26264 |
22486 |
0.22 |
chr3_88222441_88222775 | 28.70 |
Gm3764 |
predicted gene 3764 |
56 |
0.93 |
chr18_23037418_23037876 | 28.28 |
Nol4 |
nucleolar protein 4 |
1009 |
0.7 |
chr13_15759168_15760299 | 28.23 |
Gm48408 |
predicted gene, 48408 |
10387 |
0.18 |
chr8_4212633_4214018 | 27.16 |
Prr36 |
proline rich 36 |
3587 |
0.11 |
chr4_82690701_82691000 | 27.13 |
Gm11269 |
predicted gene 11269 |
1955 |
0.35 |
chr15_25754647_25755340 | 26.61 |
Myo10 |
myosin X |
2014 |
0.38 |
chr3_134339308_134339650 | 26.48 |
Gm43558 |
predicted gene 43558 |
17813 |
0.17 |
chr9_23378360_23378672 | 26.14 |
Bmper |
BMP-binding endothelial regulator |
4584 |
0.36 |
chr19_36534720_36535517 | 25.90 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chrX_135053750_135054274 | 25.89 |
3632454L22Rik |
RIKEN cDNA 3632454L22 gene |
6324 |
0.19 |
chr2_53105833_53106109 | 25.63 |
Prpf40a |
pre-mRNA processing factor 40A |
39338 |
0.2 |
chr10_106609605_106610022 | 25.62 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
7333 |
0.29 |
chr10_29143863_29144732 | 25.55 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr1_157439951_157440671 | 25.54 |
Cryzl2 |
crystallin zeta like 2 |
18266 |
0.12 |
chr3_17790108_17790687 | 25.52 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
440 |
0.82 |
chr2_22029338_22029851 | 25.23 |
Gm13337 |
predicted gene 13337 |
38232 |
0.22 |
chr3_52007190_52007930 | 25.10 |
Gm37465 |
predicted gene, 37465 |
3535 |
0.16 |
chr2_94265618_94265929 | 25.09 |
Mir670hg |
MIR670 host gene (non-protein coding) |
855 |
0.53 |
chr11_41532495_41533004 | 24.99 |
Hspd1-ps3 |
heat shock protein 1 (chaperonin), pseudogene 3 |
34012 |
0.2 |
chr17_13654565_13655321 | 24.93 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
13948 |
0.15 |
chr4_23982818_23983489 | 23.82 |
Gm28448 |
predicted gene 28448 |
49199 |
0.19 |
chr3_94477580_94477909 | 23.74 |
Celf3 |
CUGBP, Elav-like family member 3 |
551 |
0.54 |
chr4_5962411_5962640 | 23.68 |
Gm11796 |
predicted gene 11796 |
107038 |
0.07 |
chr2_65668417_65668738 | 23.66 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
109 |
0.98 |
chrX_42361986_42362271 | 23.53 |
Gm14619 |
predicted gene 14619 |
14616 |
0.27 |
chr1_42243412_42243834 | 23.49 |
Gm29664 |
predicted gene 29664 |
4928 |
0.2 |
chr13_84448589_84449243 | 23.35 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr11_32157683_32158170 | 23.28 |
Gm12109 |
predicted gene 12109 |
27079 |
0.12 |
chr7_73222623_73222960 | 23.24 |
Gm30075 |
predicted gene, 30075 |
15740 |
0.16 |
chr13_83984413_83984945 | 23.17 |
Gm4241 |
predicted gene 4241 |
3312 |
0.25 |
chr18_67497794_67498327 | 23.06 |
Spire1 |
spire type actin nucleation factor 1 |
331 |
0.86 |
chr18_45896851_45897467 | 23.04 |
A330093E20Rik |
RIKEN cDNA A330093E20 gene |
650 |
0.79 |
chr13_83721104_83721451 | 22.96 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
104 |
0.95 |
chr1_94503928_94504626 | 22.90 |
Gm7895 |
predicted gene 7895 |
34390 |
0.22 |
chr3_17789514_17789745 | 22.88 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
292 |
0.9 |
chr12_49381565_49382180 | 22.74 |
Gm34304 |
predicted gene, 34304 |
13 |
0.93 |
chr9_107629988_107631141 | 22.70 |
Gm19721 |
predicted gene, 19721 |
1975 |
0.12 |
chr2_116975074_116976384 | 22.70 |
Gm29340 |
predicted gene 29340 |
699 |
0.69 |
chr8_61309392_61309892 | 22.69 |
1700001D01Rik |
RIKEN cDNA 1700001D01 gene |
20770 |
0.18 |
chr16_33605736_33606716 | 22.65 |
Slc12a8 |
solute carrier family 12 (potassium/chloride transporters), member 8 |
9599 |
0.26 |
chr7_31127074_31128340 | 22.59 |
Scn1b |
sodium channel, voltage-gated, type I, beta |
704 |
0.47 |
chr9_16484808_16485485 | 22.41 |
Fat3 |
FAT atypical cadherin 3 |
16139 |
0.27 |
chr6_8956269_8957017 | 22.23 |
Nxph1 |
neurexophilin 1 |
6967 |
0.32 |
chr2_70113928_70114305 | 22.23 |
Myo3b |
myosin IIIB |
17818 |
0.23 |
chr15_101995547_101995886 | 22.21 |
Gm36026 |
predicted gene, 36026 |
8496 |
0.11 |
chr16_28752897_28753619 | 22.21 |
Fgf12 |
fibroblast growth factor 12 |
190 |
0.97 |
chr10_46827266_46827417 | 22.17 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr10_106469332_106470360 | 22.09 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr5_84848501_84849167 | 22.04 |
Gm21006 |
predicted gene, 21006 |
18011 |
0.3 |
chr4_107680369_107681106 | 22.01 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
223 |
0.9 |
chr12_25871193_25871842 | 21.95 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr15_18818564_18819019 | 21.94 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
17 |
0.67 |
chr13_105256983_105257274 | 21.91 |
Rnf180 |
ring finger protein 180 |
13911 |
0.24 |
chr9_102235369_102235971 | 21.83 |
Gm37260 |
predicted gene, 37260 |
38066 |
0.14 |
chr16_35591757_35592233 | 21.73 |
Gm5963 |
predicted pseudogene 5963 |
18439 |
0.18 |
chr10_87489292_87489542 | 21.71 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
4243 |
0.23 |
chr4_102534118_102534322 | 21.67 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
35875 |
0.22 |
chr5_16134186_16134593 | 21.65 |
Gm43490 |
predicted gene 43490 |
27260 |
0.22 |
chr2_127521161_127522051 | 21.65 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr3_119154908_119155345 | 21.61 |
Gm43410 |
predicted gene 43410 |
286882 |
0.01 |
chr6_10969635_10970167 | 21.51 |
AA545190 |
EST AA545190 |
4477 |
0.3 |
chr1_190727415_190727906 | 21.39 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
82803 |
0.09 |
chr5_103160778_103160955 | 21.23 |
Mapk10 |
mitogen-activated protein kinase 10 |
45063 |
0.16 |
chr16_44687184_44688343 | 21.17 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr1_185493582_185493919 | 21.11 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
3638 |
0.2 |
chr3_139885937_139886924 | 21.03 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr10_95619920_95620136 | 20.98 |
Gm33336 |
predicted gene, 33336 |
12211 |
0.13 |
chr8_98309689_98309914 | 20.96 |
Gm7192 |
predicted gene 7192 |
85138 |
0.1 |
chr18_57262231_57262735 | 20.90 |
Gm50200 |
predicted gene, 50200 |
52657 |
0.11 |
chr8_65617940_65618821 | 20.70 |
Marchf1 |
membrane associated ring-CH-type finger 1 |
145 |
0.97 |
chr16_77852087_77852674 | 20.68 |
Gm17333 |
predicted gene, 17333 |
5776 |
0.27 |
chr15_13392917_13393530 | 20.65 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr9_10269473_10269801 | 20.63 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr3_114029993_114030781 | 20.51 |
Col11a1 |
collagen, type XI, alpha 1 |
153 |
0.98 |
chr16_63806861_63807216 | 20.48 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr10_84357932_84358418 | 20.45 |
Nuak1 |
NUAK family, SNF1-like kinase, 1 |
34213 |
0.15 |
chr2_53437450_53438022 | 20.45 |
Gm13501 |
predicted gene 13501 |
39249 |
0.2 |
chr11_6528030_6529187 | 20.39 |
Snhg15 |
small nucleolar RNA host gene 15 |
155 |
0.75 |
chr14_118230432_118230634 | 20.29 |
Gm4675 |
predicted gene 4675 |
5699 |
0.14 |
chr3_37816924_37817412 | 20.23 |
Gm26404 |
predicted gene, 26404 |
14516 |
0.13 |
chr7_73647397_73647557 | 20.08 |
Gm26176 |
predicted gene, 26176 |
1388 |
0.25 |
chr2_143545112_143545712 | 20.03 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
565 |
0.54 |
chr3_20986381_20986745 | 20.03 |
Gm7488 |
predicted gene 7488 |
63002 |
0.13 |
chr5_26991582_26992107 | 20.02 |
Gm16057 |
predicted gene 16057 |
15777 |
0.25 |
chr4_64148922_64149333 | 19.98 |
8030451A03Rik |
RIKEN cDNA 8030451A03 gene |
574 |
0.83 |
chr17_56551768_56552114 | 19.97 |
Gm20219 |
predicted gene, 20219 |
2446 |
0.18 |
chr12_117344591_117345571 | 19.95 |
Gm5441 |
predicted gene 5441 |
8059 |
0.29 |
chr14_100458942_100459487 | 19.88 |
6330576A10Rik |
RIKEN cDNA 6330576A10 gene |
209 |
0.94 |
chr2_153425549_153426538 | 19.76 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr15_66240081_66240411 | 19.73 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
45805 |
0.14 |
chr13_99459018_99459548 | 19.72 |
Map1b |
microtubule-associated protein 1B |
11663 |
0.18 |
chr6_15408025_15408409 | 19.66 |
Gm25470 |
predicted gene, 25470 |
3236 |
0.33 |
chr8_55026049_55026477 | 19.66 |
Gm45264 |
predicted gene 45264 |
2138 |
0.23 |
chr18_81251894_81252538 | 19.60 |
Gm30192 |
predicted gene, 30192 |
12475 |
0.22 |
chr11_32027499_32027720 | 19.48 |
Nsg2 |
neuron specific gene family member 2 |
27107 |
0.17 |
chr13_83985066_83985623 | 19.46 |
Gm4241 |
predicted gene 4241 |
2647 |
0.28 |
chr14_12393119_12393544 | 19.42 |
Gm48267 |
predicted gene, 48267 |
8899 |
0.14 |
chr14_12393556_12393971 | 19.40 |
Gm48267 |
predicted gene, 48267 |
8467 |
0.14 |
chr3_40070102_40070729 | 19.38 |
Gm42785 |
predicted gene 42785 |
246838 |
0.02 |
chr14_118230672_118230848 | 19.28 |
Gm4675 |
predicted gene 4675 |
5472 |
0.14 |
chr13_15556639_15557072 | 19.15 |
Gli3 |
GLI-Kruppel family member GLI3 |
92875 |
0.07 |
chr3_17789882_17790060 | 18.97 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
14 |
0.98 |
chr7_3390495_3390823 | 18.90 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
24 |
0.89 |
chr13_74639270_74640542 | 18.84 |
Erap1 |
endoplasmic reticulum aminopeptidase 1 |
33 |
0.97 |
chr8_94154535_94154978 | 18.74 |
Mt3 |
metallothionein 3 |
2010 |
0.19 |
chr1_34006313_34006899 | 18.73 |
Dst |
dystonin |
426 |
0.8 |
chr18_8054510_8054913 | 18.72 |
Gm4833 |
predicted gene 4833 |
3508 |
0.33 |
chr5_150906447_150906658 | 18.72 |
Gm43298 |
predicted gene 43298 |
23910 |
0.17 |
chrX_170674987_170675201 | 18.71 |
Asmt |
acetylserotonin O-methyltransferase |
2450 |
0.42 |
chr3_159851998_159852454 | 18.71 |
Wls |
wntless WNT ligand secretion mediator |
3775 |
0.28 |
chr11_43747463_43748363 | 18.70 |
Ttc1 |
tetratricopeptide repeat domain 1 |
69 |
0.98 |
chr10_58227289_58228680 | 18.66 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr4_31728123_31728423 | 18.65 |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
235824 |
0.02 |
chr3_10685256_10685662 | 18.65 |
Gm37831 |
predicted gene, 37831 |
39143 |
0.17 |
chr5_150906717_150907027 | 18.58 |
Gm43298 |
predicted gene 43298 |
24230 |
0.17 |
chr13_84905442_84905636 | 18.56 |
Gm4059 |
predicted gene 4059 |
68778 |
0.12 |
chr13_97823915_97824432 | 18.56 |
Gm41031 |
predicted gene, 41031 |
1712 |
0.35 |
chr12_52010002_52010599 | 18.50 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3799 |
0.19 |
chr17_9725703_9726083 | 18.48 |
Gm34684 |
predicted gene, 34684 |
460 |
0.85 |
chr1_42693315_42693672 | 18.45 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
340 |
0.76 |
chr15_54921010_54921324 | 18.40 |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
1042 |
0.54 |
chr2_72427354_72427636 | 18.37 |
Cdca7 |
cell division cycle associated 7 |
48664 |
0.13 |
chr2_126932364_126933545 | 18.31 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr15_103518626_103518966 | 18.28 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
3876 |
0.17 |
chr13_28416864_28417183 | 18.26 |
Gm40841 |
predicted gene, 40841 |
2840 |
0.33 |
chr1_66320866_66321435 | 18.22 |
Map2 |
microtubule-associated protein 2 |
569 |
0.75 |
chr4_72384628_72385513 | 18.15 |
Gm11235 |
predicted gene 11235 |
157596 |
0.04 |
chr9_91386867_91387031 | 18.13 |
Zic4 |
zinc finger protein of the cerebellum 4 |
4539 |
0.14 |
chr12_13984416_13984607 | 18.07 |
Gm48479 |
predicted gene, 48479 |
28573 |
0.19 |
chr9_52223852_52224218 | 18.07 |
Zc3h12c |
zinc finger CCCH type containing 12C |
55463 |
0.12 |
chr12_44337938_44338345 | 18.07 |
Nrcam |
neuronal cell adhesion molecule |
8891 |
0.18 |
chr13_15714658_15715471 | 18.04 |
Gm48408 |
predicted gene, 48408 |
55056 |
0.11 |
chr3_66325480_66326023 | 18.03 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr5_27049317_27050134 | 18.02 |
Dpp6 |
dipeptidylpeptidase 6 |
332 |
0.92 |
chr3_120983308_120983464 | 18.02 |
Gm43444 |
predicted gene 43444 |
37390 |
0.16 |
chr8_71727942_71728505 | 17.94 |
Fcho1 |
FCH domain only 1 |
2507 |
0.15 |
chr2_106195082_106195233 | 17.94 |
Dcdc5 |
doublecortin domain containing 5 |
26900 |
0.21 |
chr13_83739197_83739995 | 17.94 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr13_26656976_26657325 | 17.93 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr8_96864637_96865011 | 17.92 |
Gm24132 |
predicted gene, 24132 |
208695 |
0.02 |
chr1_184066363_184066753 | 17.74 |
Dusp10 |
dual specificity phosphatase 10 |
32177 |
0.18 |
chr10_21881982_21882361 | 17.74 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
13 |
0.97 |
chr13_29826518_29826793 | 17.73 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
28776 |
0.23 |
chr18_8871292_8871740 | 17.70 |
Gm37148 |
predicted gene, 37148 |
56719 |
0.14 |
chr11_17460047_17460676 | 17.69 |
Gm12015 |
predicted gene 12015 |
161942 |
0.03 |
chr1_81520769_81521201 | 17.68 |
Gm37210 |
predicted gene, 37210 |
1356 |
0.55 |
chr15_73021189_73021788 | 17.62 |
Trappc9 |
trafficking protein particle complex 9 |
34322 |
0.18 |
chr13_18947816_18948472 | 17.59 |
Amph |
amphiphysin |
61 |
0.97 |
chr17_69230455_69230719 | 17.59 |
Epb41l3 |
erythrocyte membrane protein band 4.1 like 3 |
13049 |
0.22 |
chr10_92556536_92557110 | 17.58 |
Gm4800 |
predicted gene 4800 |
13153 |
0.16 |
chr2_174917254_174917443 | 17.58 |
Gm14616 |
predicted gene 14616 |
61059 |
0.09 |
chr1_63763173_63763740 | 17.53 |
4933402D24Rik |
RIKEN cDNA 4933402D24 gene |
5811 |
0.18 |
chr14_76032657_76033188 | 17.52 |
Gtf2f2 |
general transcription factor IIF, polypeptide 2 |
22057 |
0.18 |
chr5_70842284_70842796 | 17.51 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr18_78454680_78455309 | 17.51 |
4931439C15Rik |
RIKEN cDNA 4931439C15 gene |
21884 |
0.23 |
chr4_110050502_110051534 | 17.50 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr9_53705535_53706804 | 17.49 |
Rab39 |
RAB39, member RAS oncogene family |
63 |
0.96 |
chr7_73917720_73918558 | 17.48 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr2_152050523_152051049 | 17.45 |
AA387200 |
expressed sequence AA387200 |
26022 |
0.12 |
chr18_60923667_60923881 | 17.45 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
1844 |
0.26 |
chr3_21891883_21892491 | 17.43 |
7530428D23Rik |
RIKEN cDNA 7530428D23 gene |
91414 |
0.08 |
chr8_4677704_4678740 | 17.43 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chrX_166344291_166344543 | 17.33 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr3_118430578_118430874 | 17.28 |
Gm26871 |
predicted gene, 26871 |
402 |
0.79 |
chr14_15785133_15785550 | 17.26 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr6_127701185_127701975 | 17.26 |
Gm43634 |
predicted gene 43634 |
57140 |
0.08 |
chr10_25023823_25024169 | 17.26 |
Gm47715 |
predicted gene, 47715 |
23976 |
0.15 |
chr3_5327075_5327408 | 17.23 |
Zfhx4 |
zinc finger homeodomain 4 |
85569 |
0.09 |
chr9_56738591_56739084 | 17.21 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr5_98180681_98181156 | 17.19 |
Prdm8 |
PR domain containing 8 |
60 |
0.97 |
chr11_32002527_32003111 | 17.07 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr1_42691558_42691883 | 17.06 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
1373 |
0.31 |
chr18_60923916_60924296 | 17.02 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
1512 |
0.31 |
chr6_138754384_138754587 | 17.01 |
Igbp1b |
immunoglobulin (CD79A) binding protein 1b |
95941 |
0.08 |
chr3_16816961_16817117 | 17.00 |
Gm26485 |
predicted gene, 26485 |
6273 |
0.34 |
chr3_9173889_9174631 | 16.95 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76342 |
0.09 |
chr4_107673573_107674083 | 16.94 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
7132 |
0.13 |
chr3_88205532_88206477 | 16.89 |
Gm3764 |
predicted gene 3764 |
809 |
0.34 |
chr6_134888153_134888812 | 16.85 |
Gpr19 |
G protein-coupled receptor 19 |
650 |
0.56 |
chr1_6800590_6800877 | 16.84 |
St18 |
suppression of tumorigenicity 18 |
2058 |
0.39 |
chr2_85198668_85199051 | 16.81 |
Lrrc55 |
leucine rich repeat containing 55 |
1662 |
0.23 |
chr7_96212598_96213706 | 16.79 |
Tenm4 |
teneurin transmembrane protein 4 |
1481 |
0.42 |
chr17_9776345_9776976 | 16.75 |
4930452A19Rik |
RIKEN cDNA 4930452A19 gene |
793 |
0.69 |
chr4_65839396_65839998 | 16.70 |
Trim32 |
tripartite motif-containing 32 |
234448 |
0.02 |
chr10_118102987_118104071 | 16.70 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
42.6 | 127.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
25.8 | 77.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
20.1 | 60.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
18.7 | 74.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
17.3 | 121.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
15.9 | 63.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
15.1 | 45.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
13.4 | 40.2 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
11.7 | 58.7 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
11.5 | 34.4 | GO:0030070 | insulin processing(GO:0030070) |
11.3 | 45.0 | GO:0007412 | axon target recognition(GO:0007412) |
11.2 | 89.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
11.2 | 44.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
11.2 | 33.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
11.0 | 33.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
10.7 | 42.8 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
10.7 | 42.7 | GO:0061743 | motor learning(GO:0061743) |
10.6 | 31.7 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
10.4 | 41.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
10.3 | 41.3 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
9.6 | 48.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
9.6 | 38.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
9.4 | 37.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
9.3 | 27.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
9.2 | 73.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
8.6 | 25.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
8.5 | 68.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
8.5 | 59.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
8.3 | 16.6 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
8.2 | 16.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
8.2 | 106.8 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
8.2 | 40.9 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
8.2 | 57.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
8.1 | 40.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
8.0 | 16.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
7.9 | 23.8 | GO:0060594 | mammary gland specification(GO:0060594) |
7.8 | 7.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
7.7 | 15.4 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
7.7 | 23.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
7.5 | 15.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
7.4 | 37.1 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
7.3 | 7.3 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
7.3 | 7.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
7.2 | 43.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
7.2 | 36.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
7.2 | 79.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
7.1 | 21.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
7.1 | 7.1 | GO:0021764 | amygdala development(GO:0021764) glutamate secretion, neurotransmission(GO:0061535) |
7.0 | 42.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
7.0 | 7.0 | GO:0021586 | pons maturation(GO:0021586) |
6.9 | 13.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
6.8 | 34.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
6.7 | 20.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
6.6 | 13.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
6.5 | 19.5 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
6.5 | 32.5 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
6.5 | 25.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
6.4 | 6.4 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
6.3 | 12.7 | GO:0071873 | response to norepinephrine(GO:0071873) |
6.3 | 50.6 | GO:0071625 | vocalization behavior(GO:0071625) |
6.3 | 113.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
6.3 | 56.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
6.2 | 18.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
6.2 | 24.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
6.1 | 12.3 | GO:0060166 | olfactory pit development(GO:0060166) |
6.0 | 23.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
5.9 | 23.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
5.9 | 64.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
5.9 | 17.6 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
5.8 | 5.8 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
5.7 | 74.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
5.7 | 5.7 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
5.6 | 44.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
5.6 | 16.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
5.5 | 16.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
5.5 | 16.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
5.5 | 21.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
5.5 | 10.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
5.5 | 16.4 | GO:0001927 | exocyst assembly(GO:0001927) |
5.4 | 16.3 | GO:0010996 | response to auditory stimulus(GO:0010996) |
5.4 | 32.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
5.4 | 5.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
5.4 | 16.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
5.4 | 16.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
5.4 | 26.8 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
5.3 | 21.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
5.3 | 42.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
5.3 | 5.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
5.3 | 58.2 | GO:0008038 | neuron recognition(GO:0008038) |
5.3 | 26.4 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
5.2 | 72.7 | GO:0001964 | startle response(GO:0001964) |
5.1 | 87.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
5.1 | 10.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
5.0 | 30.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
5.0 | 10.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
5.0 | 15.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
5.0 | 49.9 | GO:0035640 | exploration behavior(GO:0035640) |
5.0 | 5.0 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
4.9 | 14.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
4.9 | 69.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
4.9 | 4.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
4.9 | 14.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.8 | 23.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
4.8 | 28.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
4.7 | 14.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
4.7 | 14.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.7 | 14.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
4.7 | 4.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
4.7 | 4.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
4.7 | 14.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
4.6 | 9.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
4.5 | 4.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
4.5 | 13.6 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
4.5 | 4.5 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
4.5 | 17.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
4.5 | 8.9 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
4.5 | 4.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
4.5 | 13.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
4.4 | 8.9 | GO:0046959 | habituation(GO:0046959) |
4.4 | 26.6 | GO:0048840 | otolith development(GO:0048840) |
4.4 | 30.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
4.4 | 4.4 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.4 | 21.8 | GO:0060278 | regulation of ovulation(GO:0060278) |
4.3 | 13.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
4.3 | 17.2 | GO:0030091 | protein repair(GO:0030091) |
4.3 | 4.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
4.3 | 55.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
4.2 | 202.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
4.2 | 12.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
4.2 | 12.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
4.2 | 12.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
4.1 | 16.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
4.1 | 20.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
4.0 | 8.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.0 | 4.0 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
4.0 | 4.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
4.0 | 8.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
4.0 | 24.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
4.0 | 8.0 | GO:0061055 | myotome development(GO:0061055) |
4.0 | 8.0 | GO:0021564 | vagus nerve development(GO:0021564) |
4.0 | 7.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
3.9 | 94.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
3.9 | 15.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.9 | 15.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.9 | 11.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
3.9 | 19.4 | GO:0060179 | male mating behavior(GO:0060179) |
3.9 | 3.9 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
3.9 | 11.6 | GO:0009196 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
3.8 | 111.6 | GO:0019228 | neuronal action potential(GO:0019228) |
3.8 | 11.5 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.8 | 11.5 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
3.8 | 15.2 | GO:0030035 | microspike assembly(GO:0030035) |
3.8 | 11.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
3.8 | 18.9 | GO:0035989 | tendon development(GO:0035989) |
3.8 | 11.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
3.8 | 11.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
3.8 | 11.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.8 | 18.8 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
3.7 | 268.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
3.7 | 14.9 | GO:0014028 | notochord formation(GO:0014028) |
3.7 | 11.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
3.7 | 18.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
3.7 | 18.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
3.7 | 11.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.7 | 14.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.6 | 10.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
3.6 | 7.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
3.6 | 10.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
3.6 | 17.9 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
3.5 | 7.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
3.5 | 10.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
3.5 | 13.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
3.5 | 13.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.4 | 37.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
3.4 | 6.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
3.4 | 10.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
3.4 | 10.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.4 | 3.4 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
3.4 | 17.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
3.4 | 10.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
3.4 | 13.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
3.3 | 6.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.3 | 10.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
3.3 | 6.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
3.3 | 3.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.3 | 9.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
3.3 | 6.5 | GO:0090427 | activation of meiosis(GO:0090427) |
3.3 | 22.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
3.2 | 9.7 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
3.2 | 9.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
3.2 | 3.2 | GO:1902896 | terminal web assembly(GO:1902896) |
3.2 | 6.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.1 | 31.5 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
3.1 | 6.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
3.1 | 99.8 | GO:0007019 | microtubule depolymerization(GO:0007019) |
3.1 | 15.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
3.1 | 3.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
3.1 | 6.2 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
3.1 | 37.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
3.1 | 6.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
3.1 | 3.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
3.1 | 3.1 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
3.0 | 6.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
3.0 | 6.0 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
3.0 | 5.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
3.0 | 8.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.9 | 8.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.9 | 14.3 | GO:0060539 | diaphragm development(GO:0060539) |
2.9 | 14.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
2.9 | 8.6 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.8 | 11.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.8 | 5.7 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
2.8 | 16.9 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
2.8 | 5.6 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
2.8 | 8.3 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
2.8 | 13.9 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.8 | 2.8 | GO:2001023 | regulation of response to drug(GO:2001023) |
2.8 | 11.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.8 | 8.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.7 | 16.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
2.7 | 10.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.7 | 24.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.7 | 5.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.7 | 5.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
2.7 | 5.4 | GO:0060676 | ureteric bud formation(GO:0060676) |
2.7 | 29.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
2.7 | 10.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
2.6 | 5.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.6 | 28.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.6 | 7.8 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
2.6 | 5.2 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
2.6 | 2.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.6 | 2.6 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) positive regulation of ubiquitin protein ligase activity(GO:1904668) |
2.6 | 2.6 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.6 | 7.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.5 | 10.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.5 | 2.5 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
2.5 | 5.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.5 | 7.5 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.5 | 20.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
2.5 | 9.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.5 | 4.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.4 | 7.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
2.4 | 4.8 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
2.4 | 7.2 | GO:0060437 | lung growth(GO:0060437) |
2.4 | 2.4 | GO:0021794 | thalamus development(GO:0021794) |
2.4 | 4.8 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.4 | 7.1 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
2.4 | 7.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
2.4 | 2.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
2.4 | 4.7 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
2.4 | 4.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.3 | 11.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.3 | 28.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
2.3 | 7.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.3 | 4.7 | GO:1901656 | glycoside transport(GO:1901656) |
2.3 | 13.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
2.3 | 13.8 | GO:0042428 | serotonin metabolic process(GO:0042428) |
2.3 | 6.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.3 | 4.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.3 | 4.6 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
2.3 | 6.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
2.3 | 6.8 | GO:0019086 | late viral transcription(GO:0019086) |
2.3 | 4.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.3 | 13.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
2.2 | 4.5 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
2.2 | 6.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
2.2 | 4.4 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
2.2 | 13.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.2 | 13.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.2 | 6.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
2.2 | 6.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
2.1 | 12.9 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
2.1 | 4.3 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
2.1 | 8.6 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.1 | 10.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
2.1 | 8.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.1 | 4.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.1 | 4.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.1 | 14.7 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
2.1 | 4.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
2.1 | 8.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
2.1 | 8.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
2.1 | 6.2 | GO:0086009 | membrane repolarization(GO:0086009) |
2.1 | 8.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
2.1 | 10.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
2.1 | 4.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
2.0 | 2.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
2.0 | 10.2 | GO:0090383 | phagosome acidification(GO:0090383) |
2.0 | 6.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.0 | 8.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
2.0 | 2.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
2.0 | 14.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
2.0 | 20.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
2.0 | 13.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
2.0 | 4.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
2.0 | 9.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
2.0 | 2.0 | GO:0006266 | DNA ligation(GO:0006266) |
2.0 | 3.9 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.0 | 5.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
2.0 | 2.0 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
2.0 | 13.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
2.0 | 2.0 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.9 | 11.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
1.9 | 5.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.9 | 5.8 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.9 | 5.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.9 | 7.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.9 | 9.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.9 | 5.7 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
1.9 | 5.7 | GO:0045759 | negative regulation of action potential(GO:0045759) |
1.9 | 5.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.9 | 7.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.9 | 3.8 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
1.9 | 3.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.9 | 5.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.9 | 3.8 | GO:0060005 | vestibular reflex(GO:0060005) |
1.9 | 3.8 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.9 | 3.8 | GO:0051940 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
1.9 | 1.9 | GO:2000018 | regulation of male gonad development(GO:2000018) |
1.9 | 18.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
1.9 | 3.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.9 | 1.9 | GO:1903998 | regulation of eating behavior(GO:1903998) |
1.9 | 3.7 | GO:0006868 | glutamine transport(GO:0006868) |
1.9 | 11.1 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
1.8 | 5.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.8 | 1.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
1.8 | 9.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.8 | 3.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
1.8 | 25.6 | GO:1902668 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
1.8 | 30.5 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.8 | 26.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
1.8 | 3.6 | GO:0031296 | B cell costimulation(GO:0031296) |
1.8 | 5.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.8 | 3.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
1.8 | 1.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.8 | 7.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.8 | 7.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.7 | 7.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
1.7 | 12.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.7 | 3.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.7 | 17.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
1.7 | 6.9 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.7 | 44.6 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.7 | 3.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.7 | 6.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.7 | 8.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
1.7 | 5.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.7 | 5.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.7 | 39.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
1.7 | 8.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.7 | 3.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.7 | 5.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.7 | 6.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.7 | 8.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.7 | 5.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.7 | 3.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
1.7 | 1.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.6 | 1.6 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.6 | 1.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.6 | 6.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.6 | 6.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.6 | 6.5 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.6 | 3.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.6 | 4.9 | GO:0090135 | actin filament branching(GO:0090135) |
1.6 | 14.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.6 | 19.5 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
1.6 | 4.9 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.6 | 4.9 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.6 | 3.2 | GO:0097503 | sialylation(GO:0097503) |
1.6 | 3.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.6 | 4.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
1.6 | 4.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.6 | 1.6 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.6 | 3.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.6 | 4.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.6 | 3.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.6 | 1.6 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.6 | 3.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
1.6 | 7.8 | GO:0001696 | gastric acid secretion(GO:0001696) |
1.6 | 6.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.6 | 4.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.6 | 1.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
1.6 | 3.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.5 | 4.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.5 | 12.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.5 | 4.6 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
1.5 | 1.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.5 | 1.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.5 | 4.5 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.5 | 3.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.5 | 4.5 | GO:0002254 | kinin cascade(GO:0002254) |
1.5 | 7.4 | GO:0015808 | L-alanine transport(GO:0015808) |
1.5 | 3.0 | GO:0015755 | fructose transport(GO:0015755) |
1.5 | 10.3 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.5 | 7.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.5 | 1.5 | GO:0030432 | peristalsis(GO:0030432) |
1.5 | 1.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.5 | 19.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.5 | 2.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.4 | 2.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.4 | 5.8 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.4 | 4.3 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
1.4 | 5.8 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
1.4 | 5.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.4 | 8.6 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
1.4 | 2.9 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
1.4 | 16.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.4 | 2.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.4 | 5.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.4 | 6.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.4 | 6.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.4 | 4.2 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.4 | 4.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.4 | 4.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
1.4 | 9.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.4 | 1.4 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
1.4 | 4.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.4 | 5.4 | GO:0035627 | ceramide transport(GO:0035627) |
1.4 | 4.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.4 | 1.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.4 | 13.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.3 | 8.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.3 | 5.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.3 | 6.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.3 | 5.3 | GO:0022038 | corpus callosum development(GO:0022038) |
1.3 | 4.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.3 | 2.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.3 | 5.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.3 | 5.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.3 | 7.9 | GO:0015074 | DNA integration(GO:0015074) |
1.3 | 3.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.3 | 6.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.3 | 3.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.3 | 3.9 | GO:0046098 | guanine metabolic process(GO:0046098) |
1.3 | 6.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.3 | 1.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.3 | 3.9 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.3 | 1.3 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
1.3 | 1.3 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.3 | 7.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.3 | 18.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.3 | 24.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
1.3 | 3.8 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.3 | 8.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
1.3 | 7.6 | GO:0060736 | prostate gland growth(GO:0060736) |
1.3 | 6.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.3 | 2.5 | GO:0008355 | olfactory learning(GO:0008355) |
1.3 | 3.8 | GO:0042891 | antibiotic transport(GO:0042891) |
1.2 | 6.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.2 | 2.5 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.2 | 134.1 | GO:0007626 | locomotory behavior(GO:0007626) |
1.2 | 2.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.2 | 6.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.2 | 4.9 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.2 | 6.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.2 | 6.1 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.2 | 6.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.2 | 3.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 8.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
1.2 | 6.0 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.2 | 6.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.2 | 3.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.2 | 15.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.2 | 4.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.2 | 8.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
1.2 | 4.7 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.2 | 5.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.2 | 5.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.2 | 10.5 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
1.2 | 5.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.2 | 2.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.2 | 1.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
1.2 | 10.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.2 | 5.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.2 | 3.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.2 | 8.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.2 | 3.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.2 | 3.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.1 | 10.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
1.1 | 4.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
1.1 | 3.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
1.1 | 4.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.1 | 1.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.1 | 64.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
1.1 | 2.3 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.1 | 1.1 | GO:0002339 | B cell selection(GO:0002339) |
1.1 | 1.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.1 | 5.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.1 | 29.0 | GO:0007340 | acrosome reaction(GO:0007340) |
1.1 | 3.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.1 | 2.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.1 | 73.1 | GO:0097485 | neuron projection guidance(GO:0097485) |
1.1 | 5.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.1 | 2.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.1 | 7.6 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
1.1 | 1.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
1.1 | 2.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
1.1 | 2.2 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.1 | 5.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.1 | 2.2 | GO:0090148 | membrane fission(GO:0090148) |
1.1 | 5.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
1.1 | 5.4 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.1 | 4.3 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
1.1 | 2.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.1 | 4.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.0 | 2.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.0 | 3.1 | GO:0008306 | associative learning(GO:0008306) |
1.0 | 1.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.0 | 1.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
1.0 | 5.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
1.0 | 5.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.0 | 2.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
1.0 | 1.0 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.0 | 12.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.0 | 2.0 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.0 | 11.2 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
1.0 | 3.0 | GO:0030242 | pexophagy(GO:0030242) |
1.0 | 3.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.0 | 23.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
1.0 | 1.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
1.0 | 1.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.0 | 1.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.0 | 9.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.0 | 1.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.0 | 5.7 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.9 | 49.0 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.9 | 3.7 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.9 | 3.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.9 | 1.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.9 | 2.8 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 2.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.9 | 6.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.9 | 8.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.9 | 4.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.9 | 5.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.9 | 2.7 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.9 | 13.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.9 | 2.7 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.9 | 4.4 | GO:0006983 | ER overload response(GO:0006983) |
0.9 | 2.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.9 | 0.9 | GO:0048665 | neuron fate specification(GO:0048665) |
0.9 | 2.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 4.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.9 | 2.6 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.9 | 1.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.9 | 1.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.9 | 2.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.9 | 2.6 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.9 | 9.4 | GO:0036065 | fucosylation(GO:0036065) |
0.9 | 12.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.9 | 1.7 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.8 | 0.8 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.8 | 2.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 3.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.8 | 3.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.8 | 4.2 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.8 | 2.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 6.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.8 | 5.8 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.8 | 19.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.8 | 8.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.8 | 0.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.8 | 22.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.8 | 0.8 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.8 | 2.4 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.8 | 10.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.8 | 2.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.8 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.8 | 4.8 | GO:0007616 | long-term memory(GO:0007616) |
0.8 | 2.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.8 | 0.8 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.8 | 2.4 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.8 | 1.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.8 | 1.5 | GO:0015705 | iodide transport(GO:0015705) |
0.8 | 1.5 | GO:2000664 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.8 | 6.9 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.8 | 3.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.8 | 2.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.8 | 1.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.7 | 3.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.7 | 0.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.7 | 3.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.7 | 3.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.7 | 13.3 | GO:0008542 | visual learning(GO:0008542) |
0.7 | 2.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.7 | 2.9 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 5.9 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.7 | 5.9 | GO:0072501 | cellular divalent inorganic anion homeostasis(GO:0072501) |
0.7 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 1.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.7 | 3.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.7 | 2.2 | GO:0032305 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) |
0.7 | 7.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.7 | 2.9 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.7 | 0.7 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.7 | 2.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 5.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.7 | 0.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.7 | 25.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.7 | 4.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.7 | 4.8 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.7 | 0.7 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.7 | 0.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.7 | 3.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 4.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.7 | 1.3 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.7 | 2.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 2.6 | GO:0021756 | striatum development(GO:0021756) |
0.6 | 0.6 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.6 | 5.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.6 | 3.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.6 | 2.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 0.6 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.6 | 1.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.6 | 0.6 | GO:0009750 | response to fructose(GO:0009750) |
0.6 | 1.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.6 | 1.3 | GO:0060618 | nipple development(GO:0060618) |
0.6 | 0.6 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.6 | 0.6 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.6 | 1.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.6 | 4.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.6 | 3.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.6 | 11.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.6 | 51.4 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.6 | 4.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 5.4 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 3.0 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.6 | 1.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 2.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.6 | 4.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 2.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 1.7 | GO:0014889 | muscle atrophy(GO:0014889) |
0.6 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.6 | 4.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.6 | 5.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 3.4 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.6 | 1.7 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.6 | 1.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.6 | 1.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 1.1 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 1.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.5 | 1.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.5 | 3.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.5 | 1.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 3.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.5 | 4.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 1.6 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.5 | 1.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 1.6 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.5 | 1.6 | GO:0035878 | nail development(GO:0035878) |
0.5 | 1.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.5 | 3.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.5 | 4.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.5 | 6.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.5 | 1.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 1.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.5 | 1.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 3.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.5 | 1.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.5 | 1.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 1.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.5 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.4 | 3.1 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.4 | 0.9 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.4 | 0.4 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.4 | 7.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.4 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.4 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.4 | 2.2 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.4 | 2.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.4 | 2.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 5.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.4 | 0.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.4 | 2.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 2.1 | GO:0060004 | reflex(GO:0060004) |
0.4 | 2.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 0.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.4 | 1.6 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.4 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.4 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) regulation of glutamate receptor signaling pathway(GO:1900449) |
0.4 | 0.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 3.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 3.2 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.4 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 0.8 | GO:0042637 | catagen(GO:0042637) |
0.4 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 1.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.4 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 2.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 3.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 1.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 1.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 0.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.4 | 5.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 0.7 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 0.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.7 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 1.4 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.7 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 3.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 1.0 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 0.3 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 1.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 0.3 | GO:0090192 | regulation of glomerulus development(GO:0090192) |
0.3 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.3 | 2.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 0.6 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.3 | 6.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.6 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 0.6 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.3 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 0.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 1.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.3 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 0.8 | GO:0046541 | saliva secretion(GO:0046541) |
0.3 | 0.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 1.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 2.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.3 | 0.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.3 | 1.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 1.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 2.9 | GO:0097576 | vacuole fusion(GO:0097576) |
0.2 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.2 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 0.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.8 | GO:0045683 | negative regulation of keratinocyte differentiation(GO:0045617) negative regulation of epidermis development(GO:0045683) |
0.2 | 0.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 1.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.2 | 0.8 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.4 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.7 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 1.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 1.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 1.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.1 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 1.7 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 1.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 2.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0061046 | mesenchymal-epithelial cell signaling(GO:0060638) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.1 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 1.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.2 | GO:1900164 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 3.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.3 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.4 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.4 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 1.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.2 | 75.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
14.0 | 42.1 | GO:0072534 | perineuronal net(GO:0072534) |
11.9 | 35.7 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
10.7 | 107.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
10.1 | 71.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
9.3 | 27.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
9.2 | 37.0 | GO:0033010 | paranodal junction(GO:0033010) |
9.2 | 18.5 | GO:0097441 | basilar dendrite(GO:0097441) |
7.7 | 61.5 | GO:0043083 | synaptic cleft(GO:0043083) |
6.9 | 76.3 | GO:0043194 | axon initial segment(GO:0043194) |
6.8 | 34.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
6.8 | 115.7 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
6.5 | 13.0 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
6.3 | 25.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
6.3 | 18.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
6.2 | 18.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
6.1 | 30.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
6.0 | 90.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
6.0 | 72.3 | GO:0032433 | filopodium tip(GO:0032433) |
5.7 | 17.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
5.5 | 38.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
5.3 | 5.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
5.2 | 238.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
5.1 | 46.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
5.1 | 10.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
5.0 | 126.0 | GO:0044295 | axonal growth cone(GO:0044295) |
5.0 | 20.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
5.0 | 30.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.7 | 47.1 | GO:0030673 | axolemma(GO:0030673) |
4.6 | 115.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
4.6 | 36.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.4 | 44.5 | GO:0031527 | filopodium membrane(GO:0031527) |
4.3 | 170.1 | GO:0043198 | dendritic shaft(GO:0043198) |
4.2 | 12.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
4.2 | 101.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
4.2 | 12.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
4.1 | 20.4 | GO:0097433 | dense body(GO:0097433) |
4.0 | 24.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
3.8 | 23.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
3.8 | 3.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
3.7 | 37.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
3.7 | 11.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.6 | 36.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
3.5 | 10.4 | GO:0043511 | inhibin complex(GO:0043511) |
3.4 | 188.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
3.2 | 12.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
3.1 | 15.7 | GO:0000235 | astral microtubule(GO:0000235) |
3.0 | 33.3 | GO:0042555 | MCM complex(GO:0042555) |
3.0 | 9.0 | GO:0036396 | MIS complex(GO:0036396) |
3.0 | 14.8 | GO:0071547 | piP-body(GO:0071547) |
2.9 | 11.8 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
2.9 | 8.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.9 | 20.5 | GO:0071437 | invadopodium(GO:0071437) |
2.9 | 5.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.9 | 8.6 | GO:0097427 | microtubule bundle(GO:0097427) |
2.8 | 16.9 | GO:0071986 | Ragulator complex(GO:0071986) |
2.8 | 8.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
2.8 | 13.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.7 | 13.7 | GO:0032584 | growth cone membrane(GO:0032584) |
2.7 | 13.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.6 | 10.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
2.6 | 7.8 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.6 | 2.6 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
2.5 | 346.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.5 | 7.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.4 | 22.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
2.4 | 2.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
2.4 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.4 | 9.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.4 | 7.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.4 | 9.5 | GO:0070876 | SOSS complex(GO:0070876) |
2.4 | 23.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
2.3 | 9.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.3 | 15.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
2.2 | 75.7 | GO:0030175 | filopodium(GO:0030175) |
2.2 | 6.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
2.2 | 13.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
2.2 | 8.8 | GO:0005883 | neurofilament(GO:0005883) |
2.2 | 30.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
2.1 | 2.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.1 | 25.2 | GO:0031045 | dense core granule(GO:0031045) |
2.1 | 39.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
2.0 | 6.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
2.0 | 4.0 | GO:0042585 | germinal vesicle(GO:0042585) |
2.0 | 16.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.0 | 2.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.9 | 5.7 | GO:0030478 | actin cap(GO:0030478) |
1.9 | 1.9 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.8 | 7.4 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.8 | 16.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.7 | 8.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.7 | 127.4 | GO:0030426 | growth cone(GO:0030426) |
1.7 | 10.3 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.7 | 21.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.7 | 15.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.6 | 6.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.6 | 96.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.6 | 3.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.6 | 10.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.5 | 9.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.5 | 112.2 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
1.5 | 4.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.5 | 4.5 | GO:0048179 | activin receptor complex(GO:0048179) |
1.4 | 84.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
1.4 | 2.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.4 | 4.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.4 | 4.1 | GO:0000802 | transverse filament(GO:0000802) |
1.3 | 5.4 | GO:0070545 | PeBoW complex(GO:0070545) |
1.3 | 5.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.3 | 1.3 | GO:0032280 | symmetric synapse(GO:0032280) |
1.3 | 3.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.3 | 15.7 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.3 | 6.5 | GO:0060076 | excitatory synapse(GO:0060076) |
1.3 | 19.4 | GO:0005614 | interstitial matrix(GO:0005614) |
1.3 | 3.8 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.3 | 10.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.2 | 5.0 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.2 | 3.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.2 | 9.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.2 | 4.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.2 | 2.4 | GO:0044308 | axonal spine(GO:0044308) |
1.2 | 1.2 | GO:0044298 | cell body membrane(GO:0044298) |
1.2 | 9.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.2 | 14.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.2 | 3.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.2 | 15.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.1 | 2.3 | GO:0097449 | astrocyte projection(GO:0097449) |
1.1 | 5.6 | GO:0043203 | axon hillock(GO:0043203) |
1.1 | 10.0 | GO:0031512 | motile primary cilium(GO:0031512) |
1.1 | 3.3 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.1 | 10.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.1 | 13.7 | GO:0097546 | ciliary base(GO:0097546) |
1.1 | 8.4 | GO:0034464 | BBSome(GO:0034464) |
1.1 | 3.2 | GO:0030891 | VCB complex(GO:0030891) |
1.0 | 7.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.0 | 15.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.0 | 4.0 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.0 | 7.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.0 | 10.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
1.0 | 3.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.0 | 3.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.0 | 1.0 | GO:0097386 | glial cell projection(GO:0097386) |
1.0 | 5.9 | GO:0002177 | manchette(GO:0002177) |
1.0 | 4.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.0 | 11.5 | GO:0034704 | calcium channel complex(GO:0034704) |
0.9 | 3.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.9 | 3.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.9 | 2.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.9 | 3.7 | GO:0044292 | dendrite terminus(GO:0044292) |
0.9 | 9.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.9 | 2.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.9 | 1.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.9 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.8 | 1.6 | GO:0071203 | WASH complex(GO:0071203) |
0.8 | 7.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.8 | 20.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.8 | 4.6 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.8 | 3.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.8 | 11.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 8.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.7 | 2.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 2.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 134.7 | GO:0030424 | axon(GO:0030424) |
0.7 | 26.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.7 | 1.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.7 | 4.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 5.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.6 | 1.9 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 1.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 1.9 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 1.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 2.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 58.8 | GO:0043005 | neuron projection(GO:0043005) |
0.6 | 0.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.6 | 1.2 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 23.1 | GO:0043204 | perikaryon(GO:0043204) |
0.6 | 1.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 1.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.5 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 2.2 | GO:0033503 | HULC complex(GO:0033503) |
0.5 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 1.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 6.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.5 | 4.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.5 | 1.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 4.8 | GO:0000800 | lateral element(GO:0000800) |
0.5 | 2.3 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 3.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.4 | 49.6 | GO:0030425 | dendrite(GO:0030425) |
0.4 | 67.8 | GO:0045202 | synapse(GO:0045202) |
0.4 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 5.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 1.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 3.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 1.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.5 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 2.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.3 | 5.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.3 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 0.9 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.3 | 0.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 3.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.7 | GO:0070187 | telosome(GO:0070187) |
0.2 | 2.8 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 2.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 18.1 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.2 | 0.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 5.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 0.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.6 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 4.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
40.0 | 120.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
24.9 | 74.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
18.9 | 56.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
17.9 | 89.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
14.6 | 58.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
13.7 | 41.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
13.5 | 67.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
12.8 | 64.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
12.5 | 37.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
12.1 | 48.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
10.2 | 30.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
10.2 | 71.2 | GO:0003680 | AT DNA binding(GO:0003680) |
8.5 | 17.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
8.2 | 24.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
8.1 | 64.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
7.6 | 144.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
7.4 | 22.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
7.3 | 29.4 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
7.2 | 36.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
7.1 | 21.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
7.1 | 21.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
6.9 | 82.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
6.3 | 18.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
6.3 | 25.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
6.1 | 18.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
6.0 | 18.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.9 | 41.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
5.7 | 11.4 | GO:0097016 | L27 domain binding(GO:0097016) |
5.6 | 61.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
5.6 | 11.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
5.5 | 33.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
5.5 | 22.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
5.4 | 5.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
5.4 | 16.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
5.4 | 5.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
5.4 | 10.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
5.3 | 32.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
5.3 | 26.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.0 | 20.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
5.0 | 20.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
4.9 | 19.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
4.8 | 28.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
4.7 | 14.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
4.7 | 93.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
4.7 | 18.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
4.6 | 4.6 | GO:0038191 | neuropilin binding(GO:0038191) |
4.6 | 27.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.6 | 50.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
4.5 | 35.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
4.5 | 22.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
4.3 | 8.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
4.3 | 4.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
4.2 | 16.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
4.1 | 16.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
4.0 | 40.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
3.9 | 47.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
3.9 | 11.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.9 | 11.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
3.8 | 11.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.8 | 11.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
3.8 | 7.6 | GO:0035939 | microsatellite binding(GO:0035939) |
3.7 | 97.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.7 | 7.4 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
3.6 | 40.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
3.6 | 82.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
3.5 | 126.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
3.5 | 14.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.5 | 86.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
3.4 | 10.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.4 | 47.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
3.3 | 16.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
3.3 | 13.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.2 | 29.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
3.2 | 64.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
3.2 | 9.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
3.1 | 40.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
3.1 | 6.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
3.1 | 12.3 | GO:0097001 | ceramide binding(GO:0097001) |
3.1 | 9.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.0 | 3.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
2.9 | 11.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.9 | 55.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
2.9 | 14.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
2.9 | 2.9 | GO:0003896 | DNA primase activity(GO:0003896) |
2.8 | 22.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
2.8 | 13.8 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.7 | 10.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.7 | 13.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
2.7 | 8.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
2.6 | 15.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.6 | 7.9 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
2.6 | 7.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
2.6 | 13.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
2.6 | 15.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
2.6 | 7.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.6 | 7.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
2.6 | 2.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
2.6 | 23.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
2.5 | 22.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
2.5 | 12.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
2.5 | 7.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.5 | 12.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.5 | 7.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.4 | 12.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
2.4 | 9.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.4 | 12.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.4 | 12.0 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
2.4 | 7.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.4 | 4.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
2.3 | 11.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.3 | 7.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
2.3 | 2.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
2.2 | 26.9 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
2.2 | 4.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.2 | 6.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
2.2 | 15.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
2.1 | 6.4 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.1 | 6.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
2.1 | 10.6 | GO:0048495 | Roundabout binding(GO:0048495) |
2.1 | 14.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.1 | 14.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.1 | 2.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
2.1 | 18.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.1 | 16.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
2.0 | 2.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
2.0 | 10.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.0 | 8.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.0 | 12.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.0 | 53.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
2.0 | 17.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
2.0 | 19.6 | GO:0051378 | serotonin binding(GO:0051378) |
1.9 | 15.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.9 | 5.8 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
1.9 | 54.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.9 | 7.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.9 | 5.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.9 | 5.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.9 | 5.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.9 | 41.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.9 | 13.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.9 | 7.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.9 | 9.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.9 | 11.2 | GO:0030957 | Tat protein binding(GO:0030957) |
1.8 | 9.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.8 | 5.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.8 | 16.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.8 | 12.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.8 | 8.8 | GO:1990254 | keratin filament binding(GO:1990254) |
1.8 | 3.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.7 | 12.2 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.7 | 5.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.7 | 27.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.7 | 1.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.7 | 8.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.7 | 18.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.7 | 6.7 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
1.6 | 9.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.6 | 18.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.6 | 51.0 | GO:0019894 | kinesin binding(GO:0019894) |
1.6 | 9.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.6 | 4.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.6 | 16.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
1.6 | 17.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.6 | 4.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.6 | 40.4 | GO:0030507 | spectrin binding(GO:0030507) |
1.5 | 6.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.5 | 6.0 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.5 | 3.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.5 | 4.4 | GO:0016015 | morphogen activity(GO:0016015) |
1.5 | 8.8 | GO:0034711 | inhibin binding(GO:0034711) |
1.4 | 7.2 | GO:0034452 | dynactin binding(GO:0034452) |
1.4 | 4.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.4 | 5.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.4 | 19.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.4 | 5.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.4 | 5.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.4 | 13.6 | GO:0005522 | profilin binding(GO:0005522) |
1.3 | 5.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.3 | 20.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.3 | 6.6 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.3 | 10.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.3 | 10.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.3 | 52.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
1.3 | 28.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.3 | 7.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.3 | 6.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.3 | 18.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.3 | 3.8 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.3 | 6.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.3 | 3.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.3 | 25.3 | GO:0003785 | actin monomer binding(GO:0003785) |
1.3 | 3.8 | GO:0050693 | LBD domain binding(GO:0050693) |
1.3 | 10.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.2 | 8.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.2 | 3.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.2 | 3.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.2 | 4.8 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.2 | 4.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.2 | 2.4 | GO:0016595 | glutamate binding(GO:0016595) |
1.2 | 3.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.2 | 3.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.2 | 7.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.2 | 15.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.2 | 3.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.1 | 15.9 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.1 | 6.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.1 | 3.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.1 | 26.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.1 | 7.6 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
1.1 | 7.6 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 3.3 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.1 | 5.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.1 | 1.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.1 | 9.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.1 | 5.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.1 | 2.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
1.1 | 21.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.0 | 26.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.0 | 20.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.0 | 5.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.0 | 4.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.0 | 5.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
1.0 | 5.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.0 | 3.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.0 | 2.9 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
1.0 | 5.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
1.0 | 21.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.0 | 1.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.9 | 15.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.9 | 5.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.9 | 2.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.9 | 1.8 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.9 | 2.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 9.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.9 | 4.3 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 1.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.8 | 9.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.8 | 2.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.8 | 2.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.8 | 4.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.8 | 4.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.8 | 3.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.8 | 17.1 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.8 | 4.9 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.8 | 2.4 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.8 | 5.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.8 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.8 | 4.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.8 | 3.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.8 | 3.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 2.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.8 | 1.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.8 | 16.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 6.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.8 | 2.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.8 | 2.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.8 | 3.8 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.8 | 3.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.8 | 2.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.7 | 1.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.7 | 3.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.7 | 2.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.7 | 3.7 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.7 | 2.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.7 | 5.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.7 | 2.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.7 | 2.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.7 | 2.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 2.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.7 | 8.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.7 | 2.6 | GO:0002054 | nucleobase binding(GO:0002054) |
0.6 | 1.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.6 | 0.6 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.6 | 3.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 0.6 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 6.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.6 | 5.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 1.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.6 | 4.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.6 | 2.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 2.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.6 | 3.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 30.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.5 | 10.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 1.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 4.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.5 | 7.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 3.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.5 | 1.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.5 | 9.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.5 | 2.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 17.7 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.5 | 11.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.5 | 2.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 10.5 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 1.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 6.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 3.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.5 | 2.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 2.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.4 | 3.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 2.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 2.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.3 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 4.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 0.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.4 | 3.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.4 | 5.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 21.7 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.4 | 2.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 11.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 3.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.6 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 0.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 3.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 2.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 26.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 1.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.3 | 1.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 1.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 11.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 38.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.2 | 2.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.2 | 3.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 3.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 3.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 2.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.2 | 0.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 2.0 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 4.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.1 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.1 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0034857 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.2 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.7 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.1 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 2.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 4.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 2.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 2.7 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 1.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.2 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 23.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 29.2 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 1.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 1.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 158.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.5 | 38.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
2.5 | 2.5 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
2.4 | 30.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.3 | 74.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
2.2 | 52.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.8 | 55.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
1.8 | 32.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.7 | 32.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.6 | 26.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.6 | 1.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.5 | 5.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.5 | 32.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.3 | 18.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.3 | 14.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.2 | 1.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.1 | 1.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.1 | 2.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.1 | 11.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 1.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.9 | 33.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.9 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.9 | 9.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.9 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.9 | 20.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 1.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.8 | 8.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 50.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.7 | 17.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 11.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 6.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 1.9 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 18.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 1.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 5.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 7.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 2.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 2.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 4.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 5.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 20.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 120.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
7.0 | 98.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
6.9 | 104.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
6.7 | 74.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
6.6 | 72.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
5.3 | 52.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
5.3 | 10.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
5.2 | 118.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
5.1 | 71.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
4.8 | 76.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
4.4 | 13.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.2 | 20.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
4.1 | 176.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.7 | 3.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
3.6 | 39.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
3.4 | 64.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
3.3 | 23.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
3.3 | 49.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
3.2 | 105.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.8 | 59.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
2.6 | 5.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
2.2 | 11.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
2.2 | 21.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
2.1 | 27.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.1 | 2.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
2.0 | 45.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.8 | 14.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
1.8 | 14.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.8 | 20.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.8 | 19.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.8 | 33.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.7 | 39.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.7 | 18.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.7 | 5.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.6 | 14.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.6 | 4.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.6 | 29.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
1.6 | 4.8 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
1.6 | 1.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.5 | 28.9 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.5 | 3.0 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
1.5 | 10.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.5 | 11.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.5 | 5.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.4 | 11.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.4 | 26.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.3 | 1.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.3 | 13.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.3 | 13.3 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.3 | 19.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.3 | 14.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.3 | 13.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.3 | 21.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.3 | 13.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.2 | 8.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.2 | 5.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.2 | 15.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
1.1 | 10.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.1 | 9.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.1 | 21.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
1.1 | 3.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.1 | 15.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.1 | 10.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
1.0 | 6.1 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.0 | 2.0 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
1.0 | 1.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.9 | 14.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.9 | 9.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.9 | 16.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.8 | 11.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.8 | 5.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 26.2 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.8 | 17.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.8 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.8 | 3.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.8 | 15.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.7 | 11.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.7 | 6.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 10.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 51.3 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.6 | 3.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.6 | 3.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.6 | 12.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.6 | 36.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.5 | 13.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.5 | 7.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.5 | 1.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 6.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.5 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 0.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 8.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 1.0 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.3 | 4.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 6.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.3 | 11.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 3.0 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 1.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 1.8 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 2.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 8.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 3.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.6 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |